Recommended Pages at zacks.com
Fresenius Promotes Awareness - Zacks.com
zacks.com — “Fresenius Promotes Awareness -Fresenius provides tips, during National Kidney Month, to detect and combat chronic kidney disease.” View full resource at zacks.com
Most Recently Shared on March 8, 2012 at 6:18 pm By:
Healthcare In Focus Health Site
It's National Kidney Month and @Fresenius is promoting awareness & detection of chronic #kidney disease http://t.co/ISp2I078 #health
Walgreen Unveils Flu Impact Report - Zacks.com
zacks.com — “Walgreen Unveils Flu Impact Report-Walgreen recently came up with findings from the first of a two-part Walgreens Flu Impact Report series” View full resource at zacks.com
Most Recently Shared on September 26, 2011 at 3:57 pm By:
Robyn Liu Doctor, Family Medicine Doctor, and Physician
RT @PAFPandF : Walgreens unveils flu impact report, pointing to $7B in lost wages, 32M missed school days: http://t.co/yGcaccO0 #vaccinate
Baxter Buys Baxa for $380M - Zacks.com
zacks.com — “Baxter Buys Baxa for $380M -Baxter is buying privately-held medical devices company Baxa Corporation for $380 million.” View full resource at zacks.com
Most Recently Shared on August 31, 2011 at 4:14 pm By:
Q1 Productions Health Business
Baxter Buys Baxa for $380M - Zacks.com http://t.co/ynPT45i via @ZacksResearch #acquisition
Monsanto Fears Losing Soy Market - Zacks.com
zacks.com — “Monsanto Fears Losing Soy Market-Monsanto Co. fears losing market for Roundup Ready Soy as Dow Chemical Co. launches a genetically altered soybean seed.” View full resource at zacks.com
Most Recently Shared on August 25, 2011 at 12:24 am By:
Robyn O'Brien Health Executive
Eat This? Biggest US chemical maker launches genetically altered soybean seed threatening Big Ag's market share http://t.co/KcrX3XB #gmo
FDA Clears Roche's Drug
zacks.com — “FDA Clears Roche's Drug-Roche Holdings Ltd. recently received approval from the US Food and Administration for its drug - Zelboraf for the treatment of BRAF V600E mutation-positive, inoperable or metastatic melanoma.” View full resource at zacks.com
Most Recently Shared on August 19, 2011 at 11:54 pm By:
Merck-Ariad Drug Under EU Review - Zacks.com
zacks.com — “Merck-Ariad Drug Under EU Review-Merck & Co. Inc. and Ariad Pharmaceuticals Inc. announced that the European Medicines Agency has completed the validation process and accepted their marketing authorization application for ridaforolimus for review.” View full resource at zacks.com
Most Recently Shared on August 19, 2011 at 10:18 pm By:
Drugs and Devices OW OW Health
Merck-Ariad Drug Under EU Review - Zacks.com: Merck-Ariad Drug Under EU ReviewZacks.comMerck and Ariad Pha... http://t.co/1tD0iWY #drug
Insurance Cos Cut Lobbying Costs - Zacks.com
zacks.com — “Insurance Cos Cut Lobbying Costs-Lobbying expenses declined for most health insurance companies, such as Humana, CIGNA and Aetna in the second quarter of 2011.” View full resource at zacks.com
Most Recently Shared on August 18, 2011 at 8:25 pm By:
Insurance Cos Cut Lobbying Costs: The health-care overhaul-related bill was passed last year to protect the Amer... http://t.co/NB6kAGA
Netflix Targets the Kids - Zacks.com
zacks.com — “Netflix Targets the Kids-Netflix Inc. has started a new Internet video streaming service for children aged 12 and under.” View full resource at zacks.com
Most Recently Shared on August 17, 2011 at 8:51 pm By:
Netflix Targets the Kids http://t.co/YIa9dWT
Another GILD Combo HIV Drug Cleared - Zacks.com
zacks.com — “Another GILD Combo HIV Drug Cleared-Gilead received FDA approval for Complera, its once-daily single tablet regimen, for the treatment of HIV in previously untreated adults.” View full resource at zacks.com
Most Recently Shared on August 11, 2011 at 8:13 pm By:
Another GILD Combo HIV Drug Cleared http://bit.ly/paLyBF
Major Hurdle Cleared With ISO Certification - Zacks.com
zacks.com — “Major Hurdle Cleared With ISO Certification- Verisante Technology announced in late July that they obtained ISO 13485:2003 certification for manufacture of medical devices.” View full resource at zacks.com
Most Recently Shared on August 5, 2011 at 7:08 pm By:
Drugs and Devices OW OW Health
Major Hurdle Cleared With ISO Certification - Zacks.com: Major Hurdle Cleared With ISO CertificationZ... http://bit.ly/odHai1 #MedDevice
Stock Market Research - Zacks Investment Research
zacks.com — “Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.” View full resource at zacks.com
Most Recently Shared on August 4, 2011 at 4:52 pm By:
Philips Medical News Health Business
MERGE HEALTHCARE (MRGE): UPGRADED BY RW BAIRD http://bit.ly/oQQHFg - #imaging
Gallup-Healthways Report Well-Being - Zacks.com
zacks.com — “Gallup-Healthways Report Well-Being-Healthways reported that the Well Being Index composite score remained relatively high in June 2011.” View full resource at zacks.com
Most Recently Shared on August 3, 2011 at 7:15 pm By:
Gallup-Healthways Report Well-Being http://bit.ly/q3Y10F
Stock Market Research - Zacks Investment Research
zacks.com — “Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.” View full resource at zacks.com
Most Recently Shared on July 25, 2011 at 9:23 pm By:
TRADING HIGHER ON HEAVY VOLUME ARE SHARES OF LIFE TIME FITNESS ON 1.1X ABOVE ... http://bit.ly/o0u0ga
Forest Seeks FDA Nod for COPD Drug - Zacks.com
zacks.com — “Forest Seeks FDA Nod for COPD Drug-Forest and partner Almirall, S.A. submitted a new drug application to the FDA for their COPD candidate, aclidinium bromide.” View full resource at zacks.com
Most Recently Shared on July 2, 2011 at 2:32 am By:
Michael Blaiss, MD Doctor, Allergist, and Physician
Forest Seeks FDA Nod for COPD Drug, Aclidinium, a once a day anticholinergic agent -http://goo.gl/FCLRt
Stock Market Research - Zacks Investment Research
zacks.com — “Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.” View full resource at zacks.com
Most Recently Shared on July 1, 2011 at 3:49 pm By:
LIFE TIME FITNESS BREAKS ABOVE 3-DAY TRADING RANGE AT $39.45 (LTM) http://bit.ly/mEmSgA
